Pipeline

PROGRAM

INDICATIONS

DISCOVERY

PRE-CLINICAL

PHASE 1/2

PIVOTAL

Partner

CAR-T (Off-the-Shelf)

T-ALL/LBL

Memory NK (1:1)

AML

AML

Asia (China, HK, Macao, Taiwan & Singapore)

Memory NK (Off-the-Shelf)

AML

Solid Tumors

+ mAb

Solid Tumors

Engineered

AML = Acute Myeloid Leukemia
T-ALL = T-cell Acute Lymphoblastic Leukemia
LBL = Lymphoblastic Lymphoma
mAb = Monoclonal Antibody

Lead Programs

WU-NK-101

Super-Charged to attack cancer

WU-CART-007

Engineered to target T-cell cancers

Next in our story
Next in our story